IRIS
COPPOLA, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 27.836
NA - Nord America 17.531
AS - Asia 11.768
SA - Sud America 2.003
Continente sconosciuto - Info sul continente non disponibili 926
AF - Africa 180
OC - Oceania 8
Totale 60.252
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 18.132
US - Stati Uniti d'America 16.981
SG - Singapore 4.337
IE - Irlanda 3.076
IT - Italia 2.260
CN - Cina 2.167
HK - Hong Kong 2.011
BR - Brasile 1.679
VN - Vietnam 1.363
UA - Ucraina 983
GB - Regno Unito 979
DE - Germania 936
KR - Corea 474
IN - India 363
JP - Giappone 349
FI - Finlandia 314
TR - Turchia 252
GR - Grecia 251
SE - Svezia 236
CA - Canada 231
FR - Francia 199
AR - Argentina 133
BD - Bangladesh 96
AT - Austria 84
NL - Olanda 83
MX - Messico 69
IQ - Iraq 67
PL - Polonia 59
ZA - Sudafrica 54
EC - Ecuador 51
BE - Belgio 46
PK - Pakistan 43
CO - Colombia 42
ES - Italia 40
ID - Indonesia 39
CR - Costa Rica 30
CZ - Repubblica Ceca 28
HN - Honduras 28
JM - Giamaica 27
TT - Trinidad e Tobago 26
MA - Marocco 25
GT - Guatemala 23
RS - Serbia 22
SV - El Salvador 22
EG - Egitto 21
GP - Guadalupe 21
NI - Nicaragua 21
PE - Perù 21
UZ - Uzbekistan 21
PR - Porto Rico 20
VE - Venezuela 20
PY - Paraguay 19
CW - ???statistics.table.value.countryCode.CW??? 18
RO - Romania 18
CL - Cile 16
IR - Iran 16
DZ - Algeria 15
LT - Lituania 15
AZ - Azerbaigian 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
JO - Giordania 12
KZ - Kazakistan 12
BO - Bolivia 11
MY - Malesia 11
PH - Filippine 11
TW - Taiwan 11
DO - Repubblica Dominicana 10
EE - Estonia 10
KE - Kenya 10
UY - Uruguay 10
AL - Albania 9
DK - Danimarca 9
EU - Europa 9
SA - Arabia Saudita 9
CH - Svizzera 8
KG - Kirghizistan 8
NP - Nepal 8
SN - Senegal 8
BB - Barbados 7
ET - Etiopia 7
GE - Georgia 7
LB - Libano 7
PT - Portogallo 7
MK - Macedonia 6
PA - Panama 6
AM - Armenia 5
HU - Ungheria 5
SY - Repubblica araba siriana 5
AU - Australia 4
BG - Bulgaria 4
LV - Lettonia 4
NG - Nigeria 4
OM - Oman 4
PS - Palestinian Territory 4
QA - Qatar 4
SC - Seychelles 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
Totale 59.298
Salva come PNG Salva come JPEG
Città #
Moscow 6.590
Dublin 3.074
Hong Kong 1.985
Santa Clara 1.803
Singapore 1.739
San Jose 1.672
Ashburn 1.523
Jacksonville 1.484
Council Bluffs 1.089
Chandler 990
Chicago 577
Wilmington 549
Seoul 472
Ho Chi Minh City 466
Princeton 412
Falls Church 345
Hanoi 341
Milan 330
Roxbury 315
Bremen 309
Hefei 306
Beijing 299
New York 276
Dallas 248
Naples 223
Ann Arbor 221
Medford 213
Cambridge 207
Caserta 203
Bengaluru 199
The Dalles 198
Boardman 157
Los Angeles 155
São Paulo 140
Munich 128
Woodbridge 111
Houston 103
Miano 102
Da Nang 100
Rome 100
San Mateo 99
Des Moines 92
Memphis 79
Orem 76
Nuremberg 61
Frankfurt am Main 53
Helsinki 51
Jinan 51
Mountain View 50
Phoenix 50
Washington 50
Rio de Janeiro 49
Amsterdam 48
Atlanta 48
Aversa 48
Brasília 48
Haiphong 48
Tokyo 48
Chennai 46
Nanjing 46
Montreal 45
Brussels 44
Napoli 43
Vienna 41
London 40
Warsaw 38
Düsseldorf 37
Istanbul 33
Toronto 33
Belo Horizonte 31
Guangzhou 31
Manchester 30
Brooklyn 29
North Bergen 29
Auburn Hills 28
Porto Alegre 28
Shanghai 28
Tianjin 28
Hangzhou 27
San Francisco 26
Biên Hòa 25
Campinas 25
Curitiba 25
Hải Dương 25
Paris 25
Shenyang 25
Denver 24
Hillsboro 24
Kochi 24
Marano 24
Brno 23
Norwalk 23
Stockholm 23
Bologna 22
Boston 22
Falkenstein 22
Johannesburg 22
Philadelphia 22
Baghdad 21
Mumbai 21
Totale 32.031
Salva come PNG Salva come JPEG
Nome #
The role of bacterial colonization of the suture thread in early identification and targeted antibiotic treatment of surgical site infections: A prospective cohort study 1.392
Anticoagulant treatment in COVID-19: a narrative review 222
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 221
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 216
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 215
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 206
Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven hepatitis C: a multicenter study 200
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 200
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 196
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 196
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 195
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 194
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 191
Prevalence and associated risk factors of latent tuberculosis infection among undergraduate and postgraduate dental students: A retrospective study 191
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 190
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 188
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 187
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 187
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 186
Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme? 184
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 184
Biochemical predictors of diabetic foot osteomyelitis: A potential diagnostic role for parathormone 183
(INVITED)Quantitative detection of SARS-CoV-2 virions in aqueous mediums by IoT optical fiber sensors 181
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 181
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 181
Erratum: Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme (Journal of Occupational Medicine and Toxicology (2015) 10:41) 180
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 179
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 177
Current Views on Infective Endocarditis: Changing Epidemiology, Improving Diagnostic Tools and Centering the Patient for Up-to-Date Management 177
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 176
Absence of occult HCV infection in patients experiencing an immunodepression condition 176
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 172
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 172
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 172
An attempt to improve classification of HCV-correlated chronic hepatitis 171
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 170
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 170
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 169
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 169
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 168
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. 168
Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center 167
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 166
964 HBV occult infection in patients with chronic hepatitis C: a multicentric prospective study 165
HBV vaccination status among healthcare workers: A cross-sectional study 165
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 164
Impact of comorbidities on the severity of chronic hepatitis B at presentation 163
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 163
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 162
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 162
Correlation between the hepatic expression of human microRNA hsa-miR-125a-5p and the progression of fibrosis in patients with overt and occult HBV infection 162
Cardiovascular system in COVID-19: Simply a viewer or a leading actor? 162
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 161
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 161
Epidemiological, Clinical and Microbiological Characteristics of Patients with Bloodstream Infections Due to Carbapenem-Resistant K. Pneumoniae in Southern Italy: A Multicentre Study 160
Secondary Complications in COVID-19 Patients: A Case Series 160
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 160
Prevalence of latent tuberculosis infection and associated risk factors among 3,374 healthcare students in Italy 159
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 159
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 158
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 158
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 158
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 158
Absence of occult HCV infection in HIV-positive patients 157
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 156
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 154
A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study 154
Clinical and virological characteristics associated with severe acute hepatitis B 153
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 152
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 152
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 151
Hyperglycaemia on admission to hospital and COVID-19 151
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 151
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 150
An Unusual Case of a Double Tricuspid and Mitral Valves Infective Endocarditis Complicated by Multiple Septic Embolisms Secondary to an Atrial Septal Defect: A Case Report and Review of Literature 149
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 149
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 148
Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer 148
Virological patterns of HCV patients with failure to interferon-free regimens. 148
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 148
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 146
Clinical significance of hepatitis B surface antigen mutants 146
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 146
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 146
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms 145
[Virological and clinical aspects of multiple hepatitis virus infections: preliminary data of an italian multicentre study] 145
4. Infezioni da Salmonelle non-tifoidee: nuovi aspetti epidemiologici 145
[639] ANTIVIRAL TREATMENT IN CHRONIC HBV/HCV COINFECTION: VIROLOGICAL CHANGES IN THREE COMPARTMENTS (PLASMA, PBMC AND LIVER TISSUE) AND CLINICAL OUTCOME 145
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. 145
Liver microRNA hsa-miR-125a-5p may exert an oncosuppressor effect on hepatocellular carcinoma (HCC). 145
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 145
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 145
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 145
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 144
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 144
Anti-HCV IgG avidity index in acute hepatitis C. 144
The TM6SF2 E167K variant in HIV/HCV coinfection predicts severe liver fibrosis and, only for patients with HCV genotype non 3 severe steatosis. 144
A hyper-glycosilation of HBV surface major hydrophilic region characterizes HBV reactivation driven by immunosuppression and affects HBsAg recognition in vitro 144
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 143
EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS 143
Totale 17.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 215.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.611 0 0 0 124 802 61 154 63 100 240 224 843
2022/20235.509 544 176 369 298 620 320 10 241 2.710 34 101 86
2023/20242.308 177 82 131 177 815 242 30 62 26 32 143 391
2024/20257.633 49 87 54 195 1.142 1.016 1.061 680 1.161 1.160 605 423
2025/202630.152 1.164 1.467 1.486 1.435 2.531 16.800 1.575 990 1.180 688 526 310
2026/20275.574 212 721 2.270 2.371 0 0 0 0 0 0 0 0
Totale 60.252